Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 6 studies | 21% ± 3% | |
non-classical monocyte | 4 studies | 29% ± 13% |
Insufficient scRNA-seq data for expression of KLF11 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 1735.40 | 89 / 89 | 98% | 28.89 | 884 / 901 |
breast | 100% | 3902.86 | 459 / 459 | 97% | 18.50 | 1082 / 1118 |
pancreas | 99% | 2124.27 | 326 / 328 | 97% | 15.07 | 173 / 178 |
lung | 100% | 2585.89 | 576 / 578 | 97% | 18.19 | 1119 / 1155 |
intestine | 99% | 2267.72 | 956 / 966 | 96% | 13.08 | 508 / 527 |
stomach | 100% | 1702.90 | 359 / 359 | 94% | 13.91 | 270 / 286 |
ovary | 100% | 2251.21 | 180 / 180 | 94% | 16.28 | 404 / 430 |
uterus | 100% | 2261.77 | 170 / 170 | 92% | 18.48 | 423 / 459 |
esophagus | 96% | 1705.57 | 1380 / 1445 | 96% | 16.08 | 176 / 183 |
thymus | 100% | 1729.32 | 651 / 653 | 88% | 13.96 | 534 / 605 |
bladder | 100% | 2098.48 | 21 / 21 | 88% | 12.95 | 443 / 504 |
prostate | 95% | 1065.13 | 232 / 245 | 90% | 12.16 | 454 / 502 |
liver | 93% | 1638.01 | 211 / 226 | 90% | 16.46 | 367 / 406 |
skin | 86% | 2872.82 | 1554 / 1809 | 92% | 14.30 | 433 / 472 |
adrenal gland | 99% | 1714.17 | 255 / 258 | 77% | 9.15 | 176 / 230 |
adipose | 100% | 4508.43 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1753.54 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 2517.90 | 1327 / 1335 | 0% | 0 | 0 / 0 |
muscle | 95% | 1141.27 | 765 / 803 | 0% | 0 | 0 / 0 |
heart | 95% | 1235.48 | 816 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 23.40 | 42 / 45 |
brain | 29% | 283.37 | 758 / 2642 | 62% | 4.25 | 435 / 705 |
eye | 0% | 0 | 0 / 0 | 78% | 8.09 | 62 / 80 |
lymph node | 0% | 0 | 0 / 0 | 55% | 4.29 | 16 / 29 |
peripheral blood | 33% | 261.31 | 306 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1901653 | Biological process | cellular response to peptide |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_2000045 | Biological process | regulation of G1/S transition of mitotic cell cycle |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006915 | Biological process | apoptotic process |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005925 | Cellular component | focal adhesion |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | KLF11 |
Protein name | Krueppel-like factor 11 (Transforming growth factor-beta-inducible early growth response protein 2) (TGFB-inducible early growth response protein 2) (TIEG-2) Alternative protein KLF11 KLF transcription factor 11 |
Synonyms | FKLF TIEG2 |
Description | FUNCTION: Transcription factor . Activates the epsilon- and gamma-globin gene promoters and, to a much lower degree, the beta-globin gene and represses promoters containing SP1-like binding inhibiting cell growth . Represses transcription of SMAD7 which enhances TGF-beta signaling (By similarity). Induces apoptosis (By similarity). . |
Accessions | ENST00000401510.5 E7EX78 ENST00000440320.5 L8EA48 O14901 ENST00000448523.5 ENST00000535335.1 [O14901-2] B5MCC4 ENST00000540845.5 [O14901-2] C9JM94 ENST00000305883.6 [O14901-1] |